Xylem Q3 revenue $2.1B (+50% reported, +10% organic); raises FY guidance

Xylem Inc.

2023-Q3 EPS reported $1.63 revenue$5,246,000,000

Revenue $2.1B, up 50% reported, 10% organic; orders up 43% reported, 3% organic.
EPS $0.63 (up 800% YoY); adjusted EPS $0.99 (up 14% YoY).
Raises FY23 revenue guidance to ~$7.3B (+32% reported, +11% organic) and adj. EPS to $3.71–$3.73.
Adjusted EBITDA margin expanded 150 bps to 19.8%; all segments exceeded expectations.
Evoqua integration on track; backlog grew 5% organic to $5.2B including $1.3B from Evoqua.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Xylem Inc. reported quarter ended September 30, 2023 results: revenue $2.1 billion, net income $152 million, EPS $0.63 per share. Guidance raised.

Period: quarter ended September 30, 2023
Revenue: $2.1 billion
Net income: $152 million
EPS: $0.63 per share
Guidance: raised
Result: reported results

Exact text from the filing

Xylem Reports Third Quarter 2023 Results • Revenue of $2.1 billion, up 50% on a reported basis, and 10% organically • Earnings per share of $0.63, up 800%; adjusted earnings per share of $0.99, up 14% • Raising full-year revenue guidance to approximately $7.3B, up 32% from 30%, with expected organic revenue growth of 11%, up from 9% to 10% • Lifting full-year adjusted EPS guidance to $3.71 to $3.73 , from $3.50 to $3.70

View on SEC.gov

Browse all earnings releases →

Xylem Inc. filing history →

Source: SEC EDGAR

accession 0001524472-23-000039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.